CJC-1295 No DAC

CJC-1295 (without DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been modified to resist enzymatic degradation while preserving receptor specificity. It stimulates the pituitary gland to release growth hormone in a pulsatile, physiological pattern — particularly effective when co-administered with a GHRP such as ipamorelin. Its shorter half-life relative to the DAC version makes it suitable for research designs that prioritize natural GH pulse mimicry. CJC-1295 (no DAC) is among the most widely studied GHRH analogues for GH axis support.